Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double-blind, controlled, pilot study in dry skin
- PMID: 27862339
- DOI: 10.1111/jdv.14041
Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double-blind, controlled, pilot study in dry skin
Abstract
Background: Patients suffering from chronic pruritus (CP) due to dry skin with are often applying emollients containing menthol. However, topical menthol may be irritating and of weak potency in severe pruritus. Two TRPM8 agonists, (1R,2S,5R)-N-(2-(2-pyridinyl)ethyl)-2-ispropyl-5-methylcyclohexancarboxamide and menthoxypropanediol, combined as cooling compound (CC) have shown stronger activation of TRPM8 than menthol.
Objectives: Objective of this study was to evaluate the efficacy and safety of CC in alleviating pruritus in patients with dry itchy skin.
Methods: In this vehicle-controlled, double-blind, randomized (1 : 1) study, 70 dry skin patients with pruritus intensity measured by Numerical Rating Scale (NRS) ≥3, were treated twice daily over 4 weeks, either with a lotion containing CC or with its vehicle.
Results: At treatment end, pruritus, assessed by a global score, improved significantly more in the CC than in the vehicle group (79.2% vs. 47.1%; P < 0.05; primary endpoint). Also assessed by verbal rating scale (VRS) and percentual improvement, pruritus decreased significantly more in the CC group (P = 0.007/P = 0.015) compared to vehicle arm after treatment. Up to 84% of CC-treated patients reported a significant, sometimes too strong, long-lasting cooling effect. The health-related quality of life improved significantly more in the CC group (P = 0.023). Skin roughness, dryness and hydration improved significantly in both groups without significant differences in-between them. There were no severe adverse events reported.
Conclusions: Treatment of dry and pruritic skin with a lotion containing the TRPM8 agonist combination ameliorates severe pruritus and represents a possible novel treatment for the burdensome symptom. The most suitable treatment concentration needs still to be identified. ClinicalTrials.gov: NCT00669708.
© 2016 European Academy of Dermatology and Venereology.
Similar articles
-
Histamine- and pruritogen-induced itch is inhibited by a TRPM8 agonist: a randomized vehicle-controlled human trial.Br J Dermatol. 2024 May 17;190(6):885-894. doi: 10.1093/bjd/ljae054. Br J Dermatol. 2024. PMID: 38345103 Clinical Trial.
-
Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.Vet Dermatol. 2018 Feb;29(1):29-e14. doi: 10.1111/vde.12486. Epub 2017 Sep 26. Vet Dermatol. 2018. PMID: 28952176 Clinical Trial.
-
Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN® plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial.G Ital Dermatol Venereol. 2011 Oct;146(5):321-5. G Ital Dermatol Venereol. 2011. PMID: 21956268 Clinical Trial.
-
Emerging Treatments and Novel Pathways in Pruritus.J Cutan Med Surg. 2019 Sep/Oct;23(5):528-536. doi: 10.1177/1203475419852050. Epub 2019 Jun 6. J Cutan Med Surg. 2019. PMID: 31167547 Review.
-
Looking Back to Move Forward: The Current State of Research on the Clinical Applications of Camphor- and Menthol-Containing Agents.Cureus. 2023 Jul 5;15(7):e41426. doi: 10.7759/cureus.41426. eCollection 2023 Jul. Cureus. 2023. PMID: 37546095 Free PMC article. Review.
Cited by
-
Site-Specific Transient Receptor Potential Channel Mechanisms and Their Characteristics for Targeted Chronic Itch Treatment.Biomolecules. 2024 Jan 15;14(1):107. doi: 10.3390/biom14010107. Biomolecules. 2024. PMID: 38254707 Free PMC article. Review.
-
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.Clin Exp Med. 2023 Dec;23(8):4177-4197. doi: 10.1007/s10238-023-01141-x. Epub 2023 Aug 9. Clin Exp Med. 2023. PMID: 37555911 Free PMC article. Review.
-
Transient Receptor Potential Channels and Itch.Int J Mol Sci. 2022 Dec 27;24(1):420. doi: 10.3390/ijms24010420. Int J Mol Sci. 2022. PMID: 36613861 Free PMC article. Review.
-
The contribution of ion channels to shaping macrophage behaviour.Front Pharmacol. 2022 Sep 7;13:970234. doi: 10.3389/fphar.2022.970234. eCollection 2022. Front Pharmacol. 2022. PMID: 36160429 Free PMC article. Review.
-
Role of TRP ion channels in pruritus.Neurosci Lett. 2022 Jan 18;768:136379. doi: 10.1016/j.neulet.2021.136379. Epub 2021 Nov 30. Neurosci Lett. 2022. PMID: 34861341 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous